Heming Xing, Ph.D.

Lab Head, Sr. Principal Scientist
Sanofi

Poster(s):

• W183 - Multimodal Analysis of IBD Patients Coupled with Machine Learning Identifies Immunometabolism Targets for Potential Therapies
  Wednesday, June 25, 2025

  7:30am - 7:30pm East Coast USA Time

• Tu135 - Genetic, Transcriptomic and Proteomic Evidences Identify Targets with Higher Clinical Probability of Success
  Tuesday, June 24, 2025

  6:00pm - 7:30pm East Coast USA Time

• Tu141 - HSID: An Integrative Target Discovery Framework for Hidradenitis Suppurativa
  Tuesday, June 24, 2025

  6:00pm - 7:30pm East Coast USA Time